🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06830304
Enrolling by invitation Not applicable

A Multilevel Intervention to Improve Uptake of Gastrointestinal Cancer Screening: a Cluster Randomized Clinical Trial

NCT06830304 · tracked via the Priya Life Science China tracker
Sponsor
Chongqing University Cancer Hospital
Phase
Not applicable
Started
2024-04-16
Last updated
2025-02-17

Condition(s) studied

Screening Compliance

Investigational drug(s) / intervention(s)

Multi-level Education and Navigation Program for Gastrointestinal Cancer ScreeningHealth education

Multi-level Education and Navigation Program for Gastrointestinal Cancer Screening: This multi-level intervention consists of two major components implemented at community, healthcare provider, and individual levels: Education Component: 1. Community level: Public awareness campaigns and educational sessions 2. Provider level: Training on screening guidelines and communication skills 3. Individual level: Tailored educational materials and one-on-one counseling Navigation Component: 1. Patient needs assessment and barrier identification 2. Personalized navigation services including: Appointment scheduling assistance Transportation coordination Insurance/financial counseling Reminder calls/messages Social/psychological support

Health education: Education Component: 1. Community level: Public awareness campaigns and educational sessions 2. Provider level: Training on screening guidelines and communication skills

Study summary

This study is a cluster randomized controlled trial aimed at evaluating the effectiveness of a multi-level intervention strategy in improving adherence to gastrointestinal cancer screening. Communities will be randomly assigned as the unit of randomization to either intervention or control group. The study population includes community residents aged 50-74 years. Communities in the intervention group will receive multi-level interventions including health education, patient navigation services, and appointment assistance, while communities in the control group will maintain routine screening management. All participants will be followed up for 90 days to track their endoscopy appointment and completion rates. The main research question is:

Can community-based multi-level intervention effectively improve adherence to gastrointestinal cancer screening among community residents?

Eligibility

Sex
ALL
Min age
45 Years
Max age
74 Years
Healthy volunteers
Accepted
Inclusion Criteria: * high-risk individuals of gastrointestinal cancer in 45-74 years old Exclusion Criteria: * Unable to give consent * history of cancer * severe cardiac, pulmonary, brain, or renal dysfunction or any other serious disease * psychiatric illness * pregnancy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Chongqing University Cancer Hospital Chongqing Chongqing Municipality

More Chongqing University Cancer Hospital trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06830304 on ClinicalTrials.gov ↗ ← All trials in China